Search

everythinglearnresearchcommunity

for

Search:↓

Dual-targeting therapies like Janus kinase inhibitors may treat both alopecia areata and other immune diseases.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

JAK inhibitors may become the first approved treatment for alopecia areata if they are proven safe and effective.

Baricitinib is effective and cost-efficient for treating severe alopecia areata in adults.

Imatinib can cause hair loss due to lichen planopilaris.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.

Upadacitinib and oral minoxidil improved Crohn's disease and hair regrowth in a patient.

Palbociclib generally maintains or improves quality of life in advanced breast cancer patients.

Switching JAK inhibitors can lead to significant hair regrowth in severe alopecia cases.

Cialis and Finasteride could be repurposed to treat aggressive melanoma.

Abemaciclib can cause skin, hair, and nail problems, leading some patients to stop using it.

Iressa often causes skin issues like acne and dryness in lung cancer patients.

Tofacitinib may be an effective and safe treatment for adolescent alopecia areata.

JAK inhibitors effectively reduce alopecia areata symptoms in Black patients.

Vismodegib is effective for basal cell carcinoma but has severe side effects.

Secukinumab for psoriasis unexpectedly caused increased hair growth in a patient.

Using 5-α-reductase inhibitors before treatment improves outcomes for patients with metastatic renal cell carcinoma.

Adalimumab can cause complete hair loss in rare cases.

A patient with a nerve disorder died from infection complications after developing insulin resistance from a treatment.

Bullous pemphigoid can look like erythema multiforme, so awareness is needed for proper treatment.

The document concludes that side effects from Smoothened inhibitor drugs for skin cancer are reversible and can be managed with a team approach to maintain quality of life.

Imatinib mesylate can cause skin lightening, especially in Chinese patients, due to its effect on pigment production.

EGFR and MEK inhibitors reduce PD-L1 in hair follicles, possibly causing inflammation.

Some brain cancer cells avoid immune system detection, and certain treatments could target this to slow their growth; also, certain fat cell precursors help regenerate hair and skin after injury.

Systemic corticosteroids might help treat hair loss caused by alemtuzumab in MS patients.

High MUC-18/MCAM levels in blood indicate a worse outlook for melanoma patients.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

Oral tofacitinib significantly improves lichen planopilaris symptoms without adverse effects.

Higher activity in lichen planopilaris is linked to certain immune and tissue genes.